Skip to main content

Ametek Aktie - Fundamentalanalyse - Dividendenrendite KGV

Ametek (ISIN: US0311001004, WKN: 908668) Kursdatum: 17.11.2017 Kurs: 70,260 USD
Beschreibung Daten
Symbol AME
Marktkapitalisierung 16.421.869.568,00 USD
Land Vereinigte Staaten von Amerika
Indizes S&P 500
Sektor Industriegüter
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2012-07-02 - 3:2 | 2010-12-22 - 3:2 | 2006-11-28 - 3:2 | 2004-03-01 - 2:1 |
Internet www.ametek.com
Letztes Bilanz Update 23.02.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 17.11.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
23,68 21,70 0,51% 7,21 45,86 32,08 4,28 5,04

Firmenbeschreibung

 

 

 

19.

 

Quarterly Financial Data (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

First

Quarter

 

  

Second

Quarter

 

  

Third

Quarter

 

  

Fourth

Quarter

 

  

Total

Year

 

 

 

 

  

(In thousands, except

per share amounts)

 

 

 

 

2015

 

  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

 

 

 

Net sales

 

  

$

984,059

  

  

$

1,003,726

  

  

$

998,527

  

  

$

987,983

  

  

$

3,974,295

  

 

 

 

Operating

income(1)

 

  

$

220,952

  

  

$

240,319

  

  

$

237,615

  

  

$

208,830

  

  

$

907,716

  

 

 

 

Net income(1)

 

  

$

142,107

  

  

$

155,513

  

  

$

156,398

  

  

$

136,841

  

  

$

590,859

  

 

 

 

Basic earnings per

share(1)(3)

 

  

$

0.59

  

  

$

0.64

  

  

$

0.65

  

  

$

0.58

  

  

$

2.46

  

 

 

 

Diluted earnings per

share(1)(3)

 

  

$

0.59

  

  

$

0.64

  

  

$

0.65

  

  

$

0.57

  

  

$

2.45

  

 

 

 

Dividends paid per

share

 

  

$

0.09

  

  

$

0.09

  

  

$

0.09

  

  

$

0.09

  

  

$

0.36

  

 

 

 

 

 

 

 

 

 

 

 

2014

 

  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

 

 

 

Net sales

 

  

$

975,292

  

  

$

990,718

  

  

$

1,031,811

  

  

$

1,024,143

  

  

$

4,021,964

  

 

 

 

Operating

income(2)

 

  

$

221,631

  

  

$

231,728

  

  

$

218,143

  

  

$

227,084

  

  

$

898,586

  

 

 

 

Net income(2)

 

  

$

140,586

  

  

$

150,063

  

  

$

141,811

  

  

$

152,000

  

  

$

584,460

  

 

 

 

Basic earnings per

share(2)(3)

 

  

$

0.57

  

  

$

0.61

  

  

$

0.58

  

  

$

0.62

  

  

$

2.39

  

 

 

 

Diluted earnings per

share(2)(3)

 

  

$

0.57

  

  

$

0.61

  

  

$

0.57

  

  

$

0.62

  

  

$

2.37

  

 

 

 

Dividends paid per

share

 

  

$

0.06

  

  

$

0.09

  

  

$

0.09

  

  

$

0.09

  

  

$

0.33

  

 

 

 

 

 

 

 

 

(1)

 

During 2015, the Company recorded pre-tax restructuring

charges totaling $36.6 million, with $15.9 million recorded in the

first quarter of 2015 and $20.7 million recorded in the fourth

quarter of 2015. The restructuring charges had the effect of

reducing net income for 2015 by $24.7 million ($0.10 per diluted

share), with $10.8 million net income reduction ($0.04 per diluted

share) in the first quarter of 2015 and $13.9 million net income

reduction ($0.06 per diluted share) in the fourth quarter of 2015.

See Note 18.

 

 

 

 

 

 

 

(2)

 

During 2014, the Company recorded pre-tax “Zygo

integration costs” totaling $18.9 million, with $13.7 million

recorded in the third quarter of 2014 and $5.2 million recorded in

the fourth quarter of 2014, related to the Zygo acquisition. The

Zygo integration costs comprised of $10.4 million in severance

charges, with $9.1 million recorded in the third quarter of 2014

and $1.3 million recorded in the fourth quarter of 2014, a $4.5

million fair value inventory adjustment recorded in the third

quarter of 2014 and $4.0 million in other charges recorded in the

fourth quarter of 2014. The Zygo integration costs had the effect

of reducing net income for 2014 by $13.9 million ($0.05 per diluted

share), with $10.7 million net income reduction ($0.05 per diluted

share) in the third quarter of 2014 and $3.2 million net income

reduction ($0.01 per diluted share) in the fourth quarter of

2014.

 

 

 

 

 

 

 

(3)

 

The sum of quarterly earnings per share may not equal

total year earnings per share due to rounding of earnings per share

amounts, and differences in weighted average shares and equivalent

shares outstanding for each of the periods presented.

 

 

 

 

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.ametek.com